Clinical Trials Browser

Phase 2 × Carcinoma, Non-Small-Cell Lung × Acyclovir × Clear all

NCT01833143 2020-08-04

Bortezomib in KRAS-Mutant Non-Small Cell Lung Cancer in Never Smokers or Those With KRAS G12D

Phase 2 Completed

17 enrolled 11 charts

Carcinoma, Non-Small-Cell Lung